Author: healthadmin

Get the latest news in health technology, digital health and health AI with this weekly overview. This is the news for the week of April 6th to 24th. H1 launches first AI-powered platform to connect clinical trial sponsors and sites Artificial intelligence platform H1 has launched the H1 Site Network Suite. It says it is a “first of its kind” platform that connects sponsors and sites for a seamless clinical trial workflow. Through this platform, sites can capture and manage profiles, verify functionality, and complete feasibility surveys. The company said the platform deploys AI “across the entire feasibility workflow, linking…

Xtandi’s days of growth are numbered, and an unflinching Astellas expects a series of new products to more than offset the decline in its blockbuster product partnered with Pfizer in fiscal 2026. Xtandy’s global sales will reach 960.8 billion yen ($6 billion) in Astellas Pharma’s fiscal year 2025, “reaching the peak sales level expected 13 years after launch,” CEO Naoki Okamura said on an English-dubbed investor conference call on Monday. However, while sales of Xtandi rose 5.3% in fiscal 2025, Astellas expects sales of the prostate cancer drug to decline 5.3% during fiscal 2026, which ends in March 2027. Growth…

Clinical trials are defined by speed, accuracy, and visibility. Marken’s Laboratory Advantage service line is designed to do all three. In this interview, Manishaa O’Brien, director of commercial operations at Marken UPS Healthcare Precision Logistics, explains how accelerated logistics supports reliable data collection while maintaining strict sample integrity. Marken connects facilities around the world through a robust air and ground network, enabling broader patient access and consistent performance across global trials.Mr. O’Brien will highlight how central laboratories will benefit from improved accuracy, real-time tracking, and on-time performance rates of 99.5%. A dedicated alliance manager and customized logistics solutions help ensure…

As Pfizer prepares to defend its patent on its transthyretin amyloid cardiomyopathy (ATTR-CM) drug tafamidis in court this week, analysts say eleventh-hour settlements with two of the three generic drug makers involved could bode well for both the New York drugmaker and rival BridgeBio. Pfizer’s lawsuit against Dexel Pharma was dismissed without incident late last week, according to an April 24 filing with the Delaware District Court. By April 25, Cipla had similarly settled, and the Delaware court had dismissed the Pfizer lawsuit “without prejudice,” Evercore ISI analysts said in a note. Dexel, a private Israeli generic drug maker, was…

Healthcare consumer and OTC brands company Haleon has hired Richard Manso as its new U.S. chief marketing officer.His mission is to “evolve Hareon into a more agile and consumer-centric organization,” according to an April 27 statement.The company sells a number of popular household brands, including Advil, Sensodyne, Tums and Theraflu, and has become more independent from pharmaceutical companies in recent years.Haleon was once GSK’s consumer arm until the British drugmaker spun it off into a separate company in 2022. Pfizer then sold its remaining stake in the company in March 2025, a move that had been expected for years as…

Generic drug giant Sun Pharma, already India’s largest biopharmaceutical company, has doubled its size with the acquisition (PDF) of women’s health leader Organon. In an $11.75 billion acquisition, Sun acquired the drug maker, which is expected to generate $6.2 billion in sales in 2025. Sun will pay $14 per share, a 24% premium over Organon’s closing price on Friday. It also commands a premium of more than 100% to Organon’s stock price at the beginning of April. The deal, expected to be finalized by early 2027, boosted Sun’s stock price by 7% and Organon’s by 17%. The deal is the…

A new study from the University of Colorado Boulder points to a little-known brain circuit that determines whether short-term pain goes away or becomes a long-term problem. The findings suggest that this pathway plays an important role in converting temporary pain into chronic pain that lasts months or even years. The study, conducted on animals and published in the Journal of Neuroscience, focused on an area called the caudal granulo-insular cortex (CGIC). Researchers have found that shutting down this circuit can prevent the onset of chronic pain and stop pain that has already started. “Our paper used a variety of…

A single dose of the psychedelic compound psilocybin combined with behavioral counseling led to significantly higher quit rates among smokers than a standard nicotine patch combined with the same counseling. The results suggest that psychedelic treatments may offer a highly effective new approach for people struggling to overcome tobacco addiction. The results of this study were recently published in the journal JAMA network open. Smoking is the leading cause of preventable death worldwide, killing an estimated 8 million people each year. Most smokers want to quit, but breaking the biological and psychological grip of addiction is notoriously difficult. Currently available…

New evidence shows that yoga may support heart and metabolic health in people with excess weight, but its effects are modest, population-specific and far from a stand-alone solution. study: Effects of yoga on cardiometabolic health in overweight or obese adults: A systematic review and meta-analysis of randomized controlled trials. Image credit: PeopleImages/Shutterstock.com Scientists recently conducted a comprehensive systematic review and meta-analysis to evaluate the effects of yoga interventions on cardiometabolic health outcomes in overweight or obese adults. This review was published in PLOS Global Public Health. The challenges of high BMI and the role of physical activity High BMI, indicative…

Researchers have for the first time directly visualized the quantum behavior that causes superconductivity, a state in which pairs of electrons conduct electricity with zero resistance at extremely low temperatures. But what they observed was surprising. In a study published on April 15th, physical review letterThe researchers took images of individual atoms forming pairs in a specially prepared gas cooled to near absolute zero. This is the unattainable limit of the coldness of all things. This system, known as Fermi gas, allows scientists to replace electrons with atoms, allowing them to study superconductivity in a highly controlled environment. Unexpected quantum…